<DOC>
	<DOCNO>NCT01490099</DOCNO>
	<brief_summary>This trial conduct Europe . The aim trial demonstrate bioequivalence insulin detemir produce NN729 process current process healthy subject .</brief_summary>
	<brief_title>Comparison Insulin Detemir Produced Current Process NN729 Process Healthy Subjects</brief_title>
	<detailed_description />
	<mesh_term>Insulin , Globin Zinc</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<mesh_term>Insulin Detemir</mesh_term>
	<criteria>Considered generally healthy upon completion medical history physical examination judge Investigator Body mass index ( BMI ) 18.0 27.0 kg/m^2 , inclusive Nonsmoker Fasting plasma glucose ( FPG ) maximum 6.0 mmol/L Known suspect allergy trial product relate product Pregnant , breastfeed intention become pregnant use adequate contraceptive measure ( intrauterine device ( IUD ) place least 3 month , sterilisation , oral contraceptive pill ( take without difficulty least 3 month ) approve hormonal implant ) A history alcohol drug abuse</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>February 2016</verification_date>
</DOC>